Discovery of HDAC Inhibitors That Lack an Active Site Zn2+-Binding Functional Group

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalACS Medicinal Chemistry Letters
Volume3
Issue number6
Pages (from-to)505-508
ISSN1948-5875
DOIs
Publication statusPublished - Jun 2012

    Research areas

  • HDAC inhibitors, zinc binding group, cancer therapy, tetrapeptide, apicidin

ID: 112999312